Anzeige
Mehr »
Sonntag, 14.12.2025 - Börsentäglich über 12.000 News
News-Bombe: NurExone startet Human-Versuche vor FDA!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1C3B8 | ISIN: US1914592050 | Ticker-Symbol: OC50
Siehe auch COCHLEAR LIMITED
Frankfurt
12.12.25 | 08:08
74,50 Euro
-0,67 % -0,50
Branche
Gesundheitswesen
Aktienmarkt
AUSTRALIEN
1-Jahres-Chart
COCHLEAR LIMITED ADR Chart 1 Jahr
5-Tage-Chart
COCHLEAR LIMITED ADR 5-Tage-Chart
RealtimeGeldBriefZeit
73,0076,0013.12.

Aktuelle News zur COCHLEAR LIMITED ADR Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiEnvoy Medical, Inc.: Envoy Medical Completes First Set of Activations in Final Stage of Pivotal Clinical Study for its First-Of-Its-Kind Fully Implanted Acclaim(R) Cochlear Implant163White Bear Lake, Minnesota--(Newsfile Corp. - December 10, 2025) - Envoy Medical Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing...
► Artikel lesen
04.12.Envoy Medical, Inc.: Envoy Medical to Host Fireside Chat with CEO Brent Lucas and the First Acclaim(R) Cochlear Implant Patient186White Bear Lake, Minnesota--(Newsfile Corp. - December 4, 2025) - Envoy Medical Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions...
► Artikel lesen
02.12.Cochlear-aligned biotech off to a lacklustre start on the ASX3
25.11.Biocurious: Cochlear-backed Epiminder strives to raise the bar on epilepsy monitoring2
21.11.Cochlear baut Produktmanagement aus3
COCHLEAR LIMITED ADR Aktie jetzt für 0€ handeln
20.11.Envoy Medical, Inc.: Envoy Medical Secures New U.S. Patent for Innovative Cochlear Implant System Featuring a Removable Earplug Sensor and an Implanted Battery344White Bear Lake, Minnesota--(Newsfile Corp. - November 20, 2025) - Envoy Medical Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing...
► Artikel lesen
20.11.Cochlear Implant Surgery Reduces Dementia Risk by Two-thirds4
18.11.Envoy Medical, Inc.: Envoy Medical Achieves Six-Month Milestone with First 10 Patients in Acclaim(R) Cochlear Implant Clinical Trial203White Bear Lake, Minnesota--(Newsfile Corp. - November 18, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing...
► Artikel lesen
17.11.COCHLEAR LIMITED: Change in substantial holding1
12.11.COCHLEAR LIMITED: Appendix 3Y - Diggory Howitt-
12.11.COCHLEAR LIMITED: Notification regarding unquoted securities - COH-
12.11.COCHLEAR LIMITED: Ceasing to be a substantial holder-
12.11.This Cochlear-backed ASX aspirant will be targeting an epilepsy market worth north of $1 billion2
05.11.COCHLEAR LIMITED: Becoming a substantial holder-
04.11.Envoy Medical, Inc.: Envoy Medical Announces First Three Patients Enrolled in Final Stage of Acclaim(R) Cochlear Implant Pivotal Clinical Trial360White Bear Lake, Minnesota--(Newsfile Corp. - November 4, 2025) - Envoy Medical, Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing...
► Artikel lesen
29.10.Envoy Medical, Inc.: Envoy Medical Marks Three-Year Anniversary of First Patient Receiving Its Breakthrough Fully Implanted Cochlear Implant279White Bear Lake, Minnesota--(Newsfile Corp. - October 29, 2025) - Envoy Medical, Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing...
► Artikel lesen
27.10.COCHLEAR LIMITED: Application for quotation of securities - COH-
23.10.COCHLEAR LIMITED: Appendix 3Z - Glen Boreham1
23.10.COCHLEAR LIMITED: 2025 AGM Results2
22.10.COCHLEAR LIMITED: 2025 AGM Chair and CEO & President Addresses-
Weiter >>
79 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1